Bone Densitometers - Medical Devices Pipeline Product Landscape, 2021
Summary Medical Devices sector report, “Bone Densitometers - Medical Devices Pipeline Product Landscape, 2021" provides comprehensive information about the Bone Densitometers pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Bone densitometers are devices used to measure bone mineral density with techniques such as Dual-Energy X-ray Absorptiometry (DEXA), Quantitative Computed Tomography (QCT), Radiographic Absorptiometry (RA) and Quantitative Ultrasound (QUS).
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope - Extensive coverage of the Bone Densitometers under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Bone Densitometers and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
Reasons to Buy The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
- Identify and understand important and diverse types of Bone Densitometers under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date
Our reports have been used by over 10K customers, including:
The research antibodies and reagents market is projected to reach USD 16.1 billion by 2027 from USD 11.6 billion in 2022, at a CAGR of 6.7% during the forecast period. The research antibodies and reagents market evolved owing to factors such as increasing proteomics and genomics research, growing demand for antibodies for research reproducibility,...
Summary Nipro Corp (Nipro) develops, manufactures and markets pharmaceuticals, medical equipment and functional materials including glass, rubber and plastic products.The company’s products include renal products, interventional and anaesthesiology products, injection and infusion products, cardiopulmonary products, double...
Summary Elcam Medical (Elcam) is a medical device company that produces disposable medical devices and components for the OEM market, and provides novel solutions for specialized flow control needs.The company offers products, which are used in the areas of intensive care medicine, anesthesia, infection control, needle...
The global in vivo toxicology market size is projected to reach USD 6.6 billion by 2025 from USD 5.0 billion in 2020, at a CAGR of 5.5% during the forecast period. Market growth is driven largely by the increasing pharmaceutical R&D activities, innovations in animal models, the development of exclusive in vivo toxicology tests, and the increasing...
Summary Compumedics Ltd (Compumedics) is a medical device company.It develops and commercializes computer-based medical products. The company designs, develops and commercializes computer aided medical diagnostic systems.It provides product categories such as sleep diagnostics, neurology diagnostics, brain research...
Biochips are being increasingly used in the area of biomedical and biotechnological research. With the advancement of technology in the medical field, there has been a rise in adoption of biochips in proteomics, such as in microarrays. The advantages of protein biochips include low sample consumption and its inclination towards miniaturization....
Summary Massachusetts General Hospital (MGH) is a healthcare service provider which offers research, education and therapeutic care services.The hospital provides treatment and patient care services in the therapeutic areas of allergy and immunology; hematology, orthopaedics, neurology and neurosurgery, oncology, dermatology,...
Integrin Alpha V (Vitronectin Receptor Subunit Alpha or CD51 or ITGAV) - Pipeline Review, H2 2018 Summary According to the recently published report ’Integrin Alpha V - Pipeline Review, H2 2018’; Integrin Alpha V (Vitronectin Receptor Subunit Alpha or CD51 or ITGAV) pipeline Target constitutes close...
70 pages •
By Infiniti Research Limited
• Jun 2017
About Clinical Trials Consumables Clinical trials are research studies that are undertaken to test a drug or a medical device before it is launched in the market. The data generated from these studies help with the approval of the tested drug or medical device. In clinical trials, endpoints are the key results that are expected...
Integrin Alpha V (Vitronectin Receptor Subunit Alpha or CD51 or ITGAV) - Pipeline Review, H1 2018 Summary According to the recently published report ’Integrin Alpha V - Pipeline Review, H1 2018’; Integrin Alpha V (Vitronectin Receptor Subunit Alpha or CD51 or ITGAV) pipeline Target constitutes close...
Diagnostic Imaging Density
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.